Buy shares Gilead Sciences, Inc. (GILD)

GILD

64.29 $

Invest

Dividend income

4.89 $

Earnings per share

0.24 $

Price/earnings (P/E)

267.88 $

Capitalization

80.64 billion $

Sector

Healthcare

Share price Gilead Sciences, Inc. - schedule

Income and dividends

Shares outstanding

1.25 billion

Capitalization

80.64 billion $

Price/earnings (P/E)

267.88 $

Cost estimate

Earnings per share

0.24 $

Dividend rate

2.92 $

Dividend income

4.89 $

Similar promotions

All promotions

Description

Gilead Sciences, Inc. - American biopharmaceutical drug development company. The company, founded in 1987, was originally focused on the production of antiviral drugs for the treatment of HIV, hepatitis B and C, and respiratory diseases. Later, the scope of the company included research on the development of drugs aimed at the treatment of cancer. It develops antiviral drugs for the treatment of HIV, hepatitis B and C, and respiratory diseases. He is also engaged in research on the development of drugs aimed at the treatment of oncological diseases.

What currency are shares traded in Gilead Sciences, Inc. (GILD)?

Shares Gilead Sciences, Inc. (GILD) traded in currency: US dollar ($).

In which sector does Gilead Sciences, Inc.?

According to the GICS (Global Industry Classification Standard) classification, jointly developed by MSCI and Standard & Poor\'s, Gilead Sciences, Inc. refers to the sector “Healthcare".

What is the stock ticker Gilead Sciences, Inc.?

Stock ticker Gilead Sciences, Inc. or in other words code - GILD.

A ticker is a symbol for a security, commodity, or currency on an exchange.

How much is 1 share worth Gilead Sciences, Inc.?

One company share Gilead Sciences, Inc. (GILD) is worth 64.29 $ to date 24.03.23